1. Home
  2. AISP vs RFL Comparison

AISP vs RFL Comparison

Compare AISP & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Airship AI Holdings Inc.

AISP

Airship AI Holdings Inc.

N/A

Current Price

$2.04

Market Cap

99.9M

Sector

Finance

ML Signal

N/A

Logo Rafael Holdings Inc. Class B

RFL

Rafael Holdings Inc. Class B

N/A

Current Price

$1.88

Market Cap

92.6M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
AISP
RFL
Founded
2006
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Real Estate
Sector
Finance
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
99.9M
92.6M
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
AISP
RFL
Price
$2.04
$1.88
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
361.8K
87.5K
Earning Date
05-15-2026
06-10-2026
Dividend Yield
N/A
N/A
EPS Growth
132.48
28.28
EPS
N/A
N/A
Revenue
$15,321,349.00
$917,000.00
Revenue This Year
$222.88
N/A
Revenue Next Year
$5.36
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
43.96
52 Week Low
$1.69
$1.12
52 Week High
$7.20
$3.96

Technical Indicators

Market Signals
Indicator
AISP
RFL
Relative Strength Index (RSI) 49.11 41.94
Support Level $1.69 $1.86
Resistance Level $2.11 $3.96
Average True Range (ATR) 0.13 0.17
MACD 0.03 -0.00
Stochastic Oscillator 81.93 20.59

Price Performance

Historical Comparison
AISP
RFL

About AISP Airship AI Holdings Inc.

Airship AI Holdings Inc is a robust AI-driven data management platform that solves complex data challenges for large institutions operating in dynamic and mission-critical environments with rapidly increasing volumes of data being ingested from a similarly rapidly growing number of data sources. Its primary offerings include Outpost AI, Acropolis, and Airship Command. Its offerings allow customers to manage their data across the full data lifecycle, when and where need it, using a secure permission-based architecture. Airship AI's software allows customers to view structured data both in real-time as well as to conduct searches on the structured data at a later point in time.

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.

Share on Social Networks: